Latest Revenue Outlook News

Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Metro Mining Limited has reported record Q2 shipments and site EBITDA margins, driven by a fully operational expansion and a robust bauxite market. Operational challenges from a tropical storm have been resolved, and exploration activities are accelerating.

Ventia has expanded its partnership with NBN Co through a $280 million contract amendment to upgrade fibre infrastructure in the Australian Capital Territory, marking a strategic geographic expansion.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.

Mach7 Technologies maintains its FY25 revenue growth guidance with strong recurring revenue gains, despite a modest shortfall in contracted annual recurring revenue. The company also advances its share buyback program, signaling confidence in its financial position.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

Electro Optic Systems projects first-half 2025 revenue between A$40 million and A$45 million, underpinned by a major Middle East contract and a growing contract backlog now at A$170 million.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.

Etherstack has landed a $1 million contract to supply digital radio network equipment to the world’s largest iron ore producer in Western Australia, reinforcing its growth in recurring revenues. The company also reports record cash receipts in the first half of 2025, signaling strong momentum.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.